Christine Posted September 4, 2007 Posted September 4, 2007 PARIS, Sep. 4, 2007 -- Pharmaceutical company Sanofi-Aventis said seven trials of its Taxotere drug in treating non-small cell lung cancer showed a 'significant' improvement in overall survival rates versus existing treatments. Taxotere, an anti-cancer agent used in other treatments, is the company's fourth best-selling drug. Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.